Neoadjuvant Chemotherapy Plus Nephroureterectomy for Locally Advanced Upper Tract Transitional Cell Cancer

NCT00696007 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study was unable to recruit subjects meeting the study requirements.

Conditions

Transitional Cell Carcinoma

Interventions

DRUG: Gemcitabine and cisplatin
OTHER: Retrospective comparison

Sponsor

Lahey Clinic